Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Thursday 16 January, 2014

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 8903X
GlaxoSmithKline PLC
16 January 2014
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 16 January 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1597.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $52.84 per ADS following the notional re-investment of the dividend paid to shareholders on 9 January 2014.

 

 

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

18,747.264


Dr M M Slaoui


5,798.785

Mr S Dingemans

7,270.571


Mr S M Bicknell

1,966.636


Mr R G Connor

1,303.907


Mrs D P Connelly


2,446.323

Mr J Ford


257.747

Mr S A Hussain

5,721.549


Mr W C Louv


1,689.737

Mr D S Redfern

2,809.477


Ms C Thomas

3,904.742


Mr P C Thomson

1,239.860


Mr D E Troy


3,258.978

Dr P J T Vallance

6,467.246


Ms E Walmsley

3,672.173


Mrs V A Whyte

460.409


 

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

Sonja Arsenić 

Corporate Secretariat

16 January 2014

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVQLFFZFFFBBD

a d v e r t i s e m e n t